219 related articles for article (PubMed ID: 38003257)
21. A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.
Boer JC; Pan Q; Holien JK; Nguyen TB; Ascher DB; Plebanski M
Front Immunol; 2022; 13():954435. PubMed ID: 36569921
[TBL] [Abstract][Full Text] [Related]
22. Non-synonymous Single Nucleotide Polymorphisms in Human
Samanta A; Ahamed A; Alam SSM; Ali S; Shahnawaz Khan M; Al-Amri AM; Tabrez S; Hoque M
Curr Pharm Des; 2023; 29(36):2891-2901. PubMed ID: 38018194
[TBL] [Abstract][Full Text] [Related]
23. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
[TBL] [Abstract][Full Text] [Related]
24. Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
Zhang W; Shi K; Geng Q; Herbst M; Wang M; Huang L; Bu F; Liu B; Aihara H; Li F
J Virol; 2023 Aug; 97(8):e0082223. PubMed ID: 37578233
[TBL] [Abstract][Full Text] [Related]
25. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
26. Molecular Dynamics Studies on the Structural Stability Prediction of SARS-CoV-2 Variants Including Multiple Mutants.
Choi KE; Kim JM; Rhee JE; Park AK; Kim EJ; Yoo CK; Kang NS
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563345
[TBL] [Abstract][Full Text] [Related]
27. Deciphering the free energy landscapes of SARS-CoV-2 wild type and Omicron variant interacting with human ACE2.
Lan PD; Nissley DA; O'Brien EP; Nguyen TT; Li MS
J Chem Phys; 2024 Feb; 160(5):. PubMed ID: 38310477
[TBL] [Abstract][Full Text] [Related]
28. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
29. Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex.
Ching WY; Adhikari P; Jawad B; Podgornik R
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077490
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies.
Samanta A; Alam SSM; Ali S; Hoque M
Funct Integr Genomics; 2023 Jan; 23(1):36. PubMed ID: 36631570
[TBL] [Abstract][Full Text] [Related]
31. Structural Characteristics of Heparin Binding to SARS-CoV-2 Spike Protein RBD of Omicron Sub-Lineages BA.2.12.1, BA.4 and BA.5.
Shi D; Bu C; He P; Song Y; Dordick JS; Linhardt RJ; Chi L; Zhang F
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560700
[TBL] [Abstract][Full Text] [Related]
32. Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant.
Bayani F; Safaei Hashkavaei N; Uversky VN; Mozaffari-Jovin S; Sefidbakht Y
Comput Biol Med; 2022 Aug; 147():105735. PubMed ID: 35767919
[TBL] [Abstract][Full Text] [Related]
33. Exploring Conformational Landscapes and Cryptic Binding Pockets in Distinct Functional States of the SARS-CoV-2 Omicron BA.1 and BA.2 Trimers: Mutation-Induced Modulation of Protein Dynamics and Network-Guided Prediction of Variant-Specific Allosteric Binding Sites.
Verkhivker G; Alshahrani M; Gupta G
Viruses; 2023 Sep; 15(10):. PubMed ID: 37896786
[TBL] [Abstract][Full Text] [Related]
34. A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants.
Pipitò L; Reynolds CA; Mobarec JC; Vickery O; Deganutti G
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358957
[TBL] [Abstract][Full Text] [Related]
35. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
[TBL] [Abstract][Full Text] [Related]
36. Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains.
Starr TN; Greaney AJ; Stewart CM; Walls AC; Hannon WW; Veesler D; Bloom JD
PLoS Pathog; 2022 Nov; 18(11):e1010951. PubMed ID: 36399443
[TBL] [Abstract][Full Text] [Related]
37. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
[TBL] [Abstract][Full Text] [Related]
38. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM
Viruses; 2022 May; 14(5):. PubMed ID: 35632769
[TBL] [Abstract][Full Text] [Related]
39. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
Kimura I; Yamasoba D; Tamura T; Nao N; Suzuki T; Oda Y; Mitoma S; Ito J; Nasser H; Zahradnik J; Uriu K; Fujita S; Kosugi Y; Wang L; Tsuda M; Kishimoto M; Ito H; Suzuki R; Shimizu R; Begum MM; Yoshimatsu K; Kimura KT; Sasaki J; Sasaki-Tabata K; Yamamoto Y; Nagamoto T; Kanamune J; Kobiyama K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Shirakawa K; Takaori-Kondo A; Kuramochi J; Schreiber G; Ishii KJ; ; Hashiguchi T; Ikeda T; Saito A; Fukuhara T; Tanaka S; Matsuno K; Sato K
Cell; 2022 Oct; 185(21):3992-4007.e16. PubMed ID: 36198317
[TBL] [Abstract][Full Text] [Related]
40. Different aspects in explaining how mutations could affect the binding mechanism of receptor binding domain of SARS-CoV-2 spike protein in interaction with ACE2.
Jafary F; Joozdani FA; Shahzamani K; Jafari S; Mirhendi H; Ganjalikhany MR
PLoS One; 2023; 18(9):e0291210. PubMed ID: 37682927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
